CD8A and neoplasm: The anti-tumor effect of CD4+ Th1 cells is mediated through the secretion of IL-2, TNFα, and IFNγ, enhancing CD8+ T cell responses and activating macrophages and NK cells [78,79,80] (Figure 4).